- Home
- PRTA vs ASIX Comparison
PRTA vs ASIX Comparison
Compare PRTA & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- ASIX
- Stock Information
- Founded
- PRTA 2012
- ASIX 2016
- Country
- PRTA Ireland
- ASIX United States
- Employees
- PRTA N/A
- ASIX N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- ASIX Major Chemicals
- Sector
- PRTA Health Care
- ASIX Industrials
- Exchange
- PRTA Nasdaq
- ASIX Nasdaq
- Market Cap
- PRTA 802.8M
- ASIX 721.0M
- IPO Year
- PRTA N/A
- ASIX N/A
- Fundamental
- Price
- PRTA $14.01
- ASIX $29.61
- Analyst Decision
- PRTA Buy
- ASIX Strong Buy
- Analyst Count
- PRTA 7
- ASIX 2
- Target Price
- PRTA $57.67
- ASIX $39.50
- AVG Volume (30 Days)
- PRTA 476.3K
- ASIX 130.0K
- Earning Date
- PRTA 11-12-2024
- ASIX 11-01-2024
- Dividend Yield
- PRTA N/A
- ASIX 2.16%
- EPS Growth
- PRTA N/A
- ASIX N/A
- EPS
- PRTA N/A
- ASIX 1.42
- Revenue
- PRTA $133,350,000.00
- ASIX $1,570,703,000.00
- Revenue This Year
- PRTA $60.63
- ASIX $3.61
- Revenue Next Year
- PRTA N/A
- ASIX $7.24
- P/E Ratio
- PRTA N/A
- ASIX $20.92
- Revenue Growth
- PRTA N/A
- ASIX 0.98
- 52 Week Low
- PRTA $14.00
- ASIX $20.86
- 52 Week High
- PRTA $41.55
- ASIX $32.04
- Technical
- Relative Strength Index (RSI)
- PRTA 31.91
- ASIX 47.55
- Support Level
- PRTA $17.27
- ASIX $30.02
- Resistance Level
- PRTA $18.60
- ASIX $31.43
- Average True Range (ATR)
- PRTA 1.11
- ASIX 1.11
- MACD
- PRTA -0.15
- ASIX -0.01
- Stochastic Oscillator
- PRTA 0.20
- ASIX 35.79
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About ASIX AdvanSix Inc.
AdvanSix Inc. is an integrated manufacturer of Nylon 6, a polymer resin and fertilizers. Nylon 6 is a synthetic material used by customers to produce engineered plastics, fibers, filaments, and films, which in turn are used in such end-products as automotive and electronic components, carpets, sports apparel, fishing nets, and food and industrial packaging. In addition, it also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process including caprolactam, ammonium sulfate fertilizers, and other chemical intermediates. Geographically, the group operates through the United States and its business is also expanding internationally but it derives the majority of its revenue from the United States region.